15,000 second chances: Bone Marrow Transplant program celebrates new milestone

April 24, 2019 | Michael Easterling and Samantha Bonar

City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.

Continue Reading

Exercise Lowers Heart Disease Risk in Breast Cancer Patients

April 23, 2019 | Letisia Marquez

After taking part in a 16-week exercise intervention, women who had early-stage breast cancer, and who were also inactive and overweight or obese, had a lower risk of developing cardiovascular disease, according to a new study in JAMA Oncology.

Researchers detail new findings at 2019 AACR meeting

March 28, 2019 | Zen Vuong

City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.

Joanne Mortimer, M.D., named ASCO fellow, recognized for extraordinary service

March 27, 2019 | Samantha Bonar

Joanne Mortimer, M.D., was one of just 25 oncologists nationwide named a fellow of the American Society of Clinical Oncology for 2019. The distinction recognizes ASCO members for their extraordinary volunteer service, dedication and commitment to ASCO.

Diagnosis and treatment at the same time? With theranostics, it's possible

March 27, 2019 | Zen Vuong

A City of Hope scientist and his colleagues have developed a user-friendly approach to creating “theranostics” — therapy combined with diagnostics — that target specific tumors and diseases.

Vanessa Jonsson, Ph.D.: An engineer tackles CAR T cell therapy

February 13, 2019 | City of Hope

Vanessa Jonsson, Ph.D., focuses on chimeric antigen receptor (CAR) T cell therapy. Using such tools as computational analysis and mathematical modeling, she examines the complex interactions between the tumor, the patient’s immune system and the therapy to learn how the tumor evades the immune response.

Emerging tools prove effective against lymphedema

January 30, 2019 | Alison Shore

City of Hope is on a quest to minimize — and perhaps one day eradicate — lymphedema, a residual effect of cancer that produces swelling ranging from mild to uncomfortable to positively painful.

Breast cancer survivor starts living a ‘purposeful life’

December 18, 2018 | Zen Vuong

Seven City of Hope patients will welcome the New Year atop City of Hope’s 47th Rose Parade float, “Harmony of Hope.” Meet Candida Celaya, a breast cancer survivor who is using her second chance at life to give back to the community.

Can breast implants cause cancer?

November 30, 2018 | Samantha Bonar

Leslie Popplewell, M.D., discusses a recent NBC News report that highlighted the small but apparently growing risk of a rare kind of lymphoma in women who have received breast implants.

Minor diet changes can affect cancer risk, researcher finds

November 9, 2018 | City of Hope

On one hand, City of Hope's Rowan Chlebowski, M.D., Ph.D., is a medical oncologist and breast cancer expert. On the other, he’s a scientist specializing in observational studies who ranks among the most cited researchers in the world.

First-of-its-kind CAR T clinical trial enrolls HER2+ breast cancer patients with brain metastases

October 30, 2018 | City of Hope

City of Hope is now enrolling patients in a phase 1 trial evaluating the safety and efficacy of CAR T cell therapy in patients with HER2+ breast cancer that has metastasized to the brain.